Business Context and Reporting Period
Company: Amgen Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 1, 2025
Reporting Period: First Quarter 2025 (Three months ended March 31, 2025)
This filing announces the issuance of a press release containing unaudited results of operations and financial position for the first quarter of 2025. The report includes both GAAP and non-GAAP financial measures.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) but does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing outlines the methodology for calculating non-GAAP measures, including:
- Non-GAAP Measures: Earnings per share, operating income, operating margin, tax rate, and operating expenses (including cost of sales, R&D, and SG&A).
- Free Cash Flow (FCF): Defined as operating cash flow minus capital expenditures.
- Excluded Items: Acquisition-related expenses (amortization/impairment of intangibles), restructuring and cost savings charges (severance, asset impairments), and other unusual items (gains/losses on equity investments, legal settlements).
Material Changes
The filing text does not provide specific data points to quantify material changes versus the prior comparable period. It notes that acquisition-related charges and restructuring costs vary significantly in amount and timing, impacting period-over-period comparisons.
Guidance, Outlook, and Management Commentary
Management Commentary:
- Management utilizes non-GAAP measures to evaluate ongoing business performance, allocate resources, and assess results against incentive compensation targets.
- Non-GAAP measures are intended to facilitate comparisons of ongoing operations by excluding non-recurring or non-cash items associated with acquisitions and restructuring.
- FCF is presented as a supplemental measure of liquidity.
- The text does not contain specific forward-looking guidance, risk factors, or contingencies beyond the general description of variable acquisition and restructuring charges.
Investor Verification Checklist
- Review Exhibit 99.1: The actual financial figures (revenue, net income, EPS) are located in the press release attached as Exhibit 99.1, which is not included in this text.
- Reconciliation Tables: Verify the specific dollar amounts excluded from GAAP to reach non-GAAP results for acquisition amortization, restructuring, and legal settlements.
- Free Cash Flow Calculation: Confirm the specific operating cash flow and capital expenditure figures used to derive the reported FCF.
- Debt and Liquidity: Check the full press release for updated debt balances and liquidity positions as of March 31, 2025.